ArticleCancers2026

MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer.

Siri Helene Bertelsen Brandal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.